B12 supplements sold for humans are suitable for cats
in December 2024 the FDA's Pharmacy Compounding Advisory Committee voted against adding it to the final 503A bulks list, citing nonclinical toxicity, an unresolved cardiac signal, and immunogenicity risk
This question often arises among competitive athletes or individuals undergoing routine drug screening
This approach catches potential issues while they remain early and treatable
Primary Research Applications Musculoskeletal Healing Studies Extensive validation demonstrates remarkable improvements in tendon, ligament, and muscle repair with enhanced functional outcomes including increased motor function, decreased joint contracture, and preserved locomotion patterns
Mayo Clin Proc Innov Qual Outcomes